Morning Report: Bisphosphonates; T1DM in Adults; Hep B and C
Dr Arefa Cassoobhoy highlights some of this week ' s most important medical news, including new-onset type 1 diabetes in adults, treating hepatitis C, and the effect of bisphosphonates on mortality. (Source: Medscape Internal Medicine Podcast)
Source: Medscape Internal Medicine Podcast - September 30, 2016 Category: Internal Medicine Authors: Medscape Source Type: podcasts
How does maximizing shareholder value distort drug development?
With the emergence of sofobuvir, a new direct acting antiviral, treatment for Hepatitis C infection is currently undergoing it's greatest change since the discovery of the virus 25 years ago.
However Gilead, who manufacture the treatment, are under fire for the cost of the druge - around $90 000 for a course of treatment.
Victor Roy, doctoral... (Source: The BMJ Podcast)
Source: The BMJ Podcast - July 28, 2016 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
How does maximizing shareholder value distort drug development?
With the emergence of sofobuvir, a new direct acting antiviral, treatment for Hepatitis C infection is currently undergoing it's greatest change since the discovery of the virus 25 years ago.
However Gilead, who manufacture the treatment, are under fire for the cost of the druge - around $90 000 for a course of treatment.
Victor Roy, doctoral... < div class="feedflare" > < a href="http://feeds.bmj.com/~ff/bmj/podcasts?a=Jb0mLYezd1U:tNwQPGVMeOg:yIl2AUoC8zA" > < img src="http://feeds.feedburner.com/~ff/bmj/podcasts?d=yIl2AUoC8zA" border="0" > < /img > < /a > < a href="http://feeds.bmj.com/~ff/bmj/podcasts?a=Jb0mLYezd1U:...
Source: The BMJ Podcast - July 28, 2016 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts
How does maximizing shareholder value distort drug development?
With the emergence of sofobuvir, a new direct acting antiviral, treatment for Hepatitis C infection is currently undergoing it's greatest change since the discovery of the virus 25 years ago.
However Gilead, who manufacture the treatment, are under fire for the cost of the druge - around $90 000 for a course of treatment.
Victor Roy, doctoral researcher at the University of Cambridge, discusses how the new drug was discovered and came to market, and what happened to the profits from sale.
Read the full analysis:
http://www.bmj.com/content/354/bmj.i3718 (Source: The BMJ Podcast)
Source: The BMJ Podcast - July 28, 2016 Category: General Medicine Authors: BMJ Group Source Type: podcasts
TWiV 393: Lovers and livers
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler The TWiVerati revisit possible sexual transmission of Zika virus, and reveal how a cell protein that allows hepatitis C virus replication in cell culture enhances vitamin E mediated protection against lipid peroxidation. Become a patron of TWiV! Links for this episode Late sexual transmission of Zika virus (Lancet) Zika virus disease in US (CDC) Zika virus lab accident (ABC News) Mosquito eradication (virology blog) Florida mosquito control (TWiV 111) How tequila mosquito (TWiV 178) SEC14L2 allows HCV replication in cell culture (Nature) Lipid pero...
Source: This Week in Virology - MP3 Edition - June 12, 2016 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
TWiV 389: Alphabet hepatitis with Stan Lemon
Host: Vincent Racaniello Guest: Stan Lemon Vincent speaks with Stan Lemon about his career in virology, from early work on Epstein Barr virus, through making essential discoveries about hepatitis A virus, hepatitis C virus, and rhinoviruses. Links for this episode Live in Edmonton, Eh? (TWiV 235) Replication of EBV in epithelial cells (Nature) Returning to Carolina after 14 years Evolutionary origins of hepatitis A virus (TWiV 265) cre in rhinovirus genome (RNA) Naked viruses that aren't always naked (Ann Rev Virol) miR-122 and hepatitis C virus RNA (Cell Host Micr) This episode is sponsored by CuriosityStream. Get two...
Source: This Week in Virology - MP3 Edition - May 15, 2016 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
FDA Drug Safety Podcast: FDA warns of serious liver injury risk with hepatitis C treatments Viekira Pak and Technivie
On October 22, 2015 FDA announced it is warning that hepatitis C treatments Viekira Pak and Technivie can cause serious liver injury mostly in patients with underlying advanced liver disease. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - October 30, 2015 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
DCV/ASV/BCV for HCV Infection With Cirrhosis
Interview with Andrew J. Muir, MD, author of Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - May 5, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
TWiV 330: A swinging gate
Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler
The TWiVers explain how a protein platform assists the hepatitis C virus RNA polymerase to begin the task of making viral genomes.
Links for this episode
NYAS Afterschool STEM Mentoring Program
Concerns about editing the human germline (Science, Nature)
Engineering the perfect baby (MIT Tech Rev)
RNA recognition by HCV polymerase (Science)
Kickstarting an RNA polymerase (Science)
A protein platform for priming (virology blog)
Apoenzyme and holoenzyme (Wikibooks)
Ebolavirus will not become a respiratory pathogen (vir...
Source: This Week in Virology - MP3 Edition - March 29, 2015 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
TWiV 324: Viruses in the miR may appear more numerous
Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler
Guest: Lee Feinman
Lee joins the TWiV team to discuss the value of post-doctoral training, and how a cellular microRNA assists in the replication of hepatitis C virus.
Links for this episode
Spin by Robert Charles Wilson
Immunization of preterm infants (Dev Period Med)
miR-122 alters HCV translation-replication balance (Cell Host Micr)
Holding a miR to HCV (TWiV 180)
Treating hepatitis C by blocking miR-122 (virology blog)
Click chemistry (Wikip...
Source: This Week in Virology - MP3 Edition - February 15, 2015 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Is the Hep C screening expansion justified?
Until recently, hepatitis C screening was offered to people at increased risk of infection - such as intravenous drug users - but now, the US Centers for Disease Control and Prevention has recommended screening all people born between 1945 and 1965.
Kenny Lin, associate professor of family medicine at Georgetown University in Washington, DC, and... (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 14, 2015 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Is the Hep C screening expansion justified?
Until recently, hepatitis C screening was offered to people at increased risk of infection - such as intravenous drug users - but now, the US Centers for Disease Control and Prevention has recommended screening all people born between 1945 and 1965.
Kenny Lin, associate professor of family medicine at Georgetown University in Washington, DC, and Jeanne Lenzer, an investigative health journalist from New York, explain why they worry that the evidence doesn't support this expansion.
ead their analysis article:http://www.bmj.com/content/350/bmj.g7809 (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 14, 2015 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Is the Hep C screening expansion justified?
Until recently, hepatitis C screening was offered to people at increased risk of infection - such as intravenous drug users - but now, the US Centers for Disease Control and Prevention has recommended screening all people born between 1945 and 1965.
Kenny Lin, associate professor of family medicine at Georgetown University in Washington, DC, and... (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 14, 2015 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts
Is the Hep C screening expansion justified?
Until recently, hepatitis C screening was offered to people at increased risk of infection - such as intravenous drug users - but now, the US Centers for Disease Control and Prevention has recommended screening all people born between 1945 and 1965.
Kenny Lin, associate professor of family medicine at Georgetown University in Washington, DC, and Jeanne Lenzer, an investigative health journalist from New York, explain why they worry that the evidence doesn't support this expansion.
ead their analysis article:
http://www.bmj.com/content/350/bmj.g7809 (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 14, 2015 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Billy Heddins, Liver Cancer Survivor
, shares his inspiring and touching journey through liver cancer. He discusses learning that he had Hepatitis C from a long past blood transfusion, discovering that...
Author: SayYEStoHOPE
Added: 10/01/2014 (Source: Oncology Tube)
Source: Oncology Tube - October 1, 2014 Category: Cancer & Oncology Source Type: podcasts
